195 related articles for article (PubMed ID: 16123224)
1. MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10.
Nakagawa M; Hosokawa Y; Yonezumi M; Izumiyama K; Suzuki R; Tsuzuki S; Asaka M; Seto M
Blood; 2005 Dec; 106(13):4210-6. PubMed ID: 16123224
[TBL] [Abstract][Full Text] [Related]
2. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
3. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
4. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
[TBL] [Abstract][Full Text] [Related]
5. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
6. [High incidence of t (11; 18)/API2-MALT1 and BCL10 aberrant nuclear expression in pulmonary mucosa-associated lymphoid tissue lymphomas].
Li BZ; Yang WT; Lu HF; Fan YZ; Zhou XY; Shi DR
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):831-5. PubMed ID: 19080537
[TBL] [Abstract][Full Text] [Related]
7. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
Nakagawa M; Seto M; Hosokawa Y
Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
11. Multiple protein domains mediate interaction between Bcl10 and MALT1.
Langel FD; Jain NA; Rossman JS; Kingeter LM; Kashyap AK; Schaefer BC
J Biol Chem; 2008 Nov; 283(47):32419-31. PubMed ID: 18806265
[TBL] [Abstract][Full Text] [Related]
12. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal BCL10 nuclear expression and chromosomal translocation in ocular adnexal mucosa-associated lymphoid tissue lymphomas].
Li BZ; Yang WT; Zhou XY; Fan YZ; Lu HF; Shi DR
Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):545-8. PubMed ID: 19035248
[TBL] [Abstract][Full Text] [Related]
14. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
[TBL] [Abstract][Full Text] [Related]
15. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
Maes B; Demunter A; Peeters B; De Wolf-Peeters C
Blood; 2002 Feb; 99(4):1398-404. PubMed ID: 11830492
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases.
Li C; Inagaki H; Kuo TT; Hu S; Okabe M; Eimoto T
Am J Surg Pathol; 2003 Aug; 27(8):1061-9. PubMed ID: 12883238
[TBL] [Abstract][Full Text] [Related]
17. No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma.
Adachi A; Tamaru J; Kaneko K; Kuroda H; Miura I; Kojima T; Hoshino S; Ichinohasama R; Itoyama S
Pathol Int; 2004 Jan; 54(1):16-25. PubMed ID: 14674990
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Seto M
Int J Hematol; 2004 Oct; 80(3):215-23. PubMed ID: 15540895
[TBL] [Abstract][Full Text] [Related]
19. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
[TBL] [Abstract][Full Text] [Related]
20. MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.
Sagaert X; Laurent M; Baens M; Wlodarska I; De Wolf-Peeters C
Mod Pathol; 2006 Feb; 19(2):225-32. PubMed ID: 16341151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
